Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cuprina Holdings (Cayman) Limited Class A ( (CUPR) ) has shared an update.
On June 30, 2025, Cuprina Holdings provided an update on its collaborative research studies with three leading educational institutes aimed at producing collagen peptides from American bullfrog skin. These studies, started in 2024 and 2025, focus on developing applications for these peptides in cosmeceuticals and wound care products. The company is exploring marketing opportunities and testing new applications, such as microneedling patches, which could enhance wound healing. The collaborations are expected to lead to productive commercial applications, leveraging the superior properties of bullfrog collagen.
More about Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company focused on developing and commercializing products for managing chronic wounds and infertility, as well as cosmeceuticals in the health and beauty sector. The company utilizes materials derived from natural sources to create wound care products that meet international standards.
Average Trading Volume: 168,187
Learn more about CUPR stock on TipRanks’ Stock Analysis page.